Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Last week, you saw news that dense breast notification laws are working – just not as well as anyone had originally hoped. More women are learning about their particular circumstances and their individual characteristics that can place them at greater risk for an undetected breast cancer, but there is still work to do. But, do not get too discouraged. According to breast imaging expert Stamatia Destounis, M.D., FACR, with Elizabeth Wende Breast Care, there is more to be hopeful and excited about when it comes to the impact of these laws. Look for her input later this week.
For more coverage about breast density and dense breast notification laws, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Traumatic brain injury (TBI) can be devastating for any patient, and it can affect individuals differently. In a recent study from the National Institute of Neurological Disorders and Stroke, investigators have looked into how TBI can specifically affect women. Published in the Journal of Head Trauma Rehabilitation, researchers examine the growing opportunities and strategies, including imaging studies, to better understand how women experience these injuries. Keep an eye out for the study in the coming days.
For additional articles on traumatic brain injury, click here.
Bone pain from cancer can be debilitating, so effective strategies to minimize what patients experience are important. In a new study from Clinical and Translational Radiation Oncology, investigators from The Netherlands look at the efficacy of MR-Guided High Intensity Focused Ultrasound as a potential tool to relief pain in patients. Read more about their findings later this week.
For more coverage on bone pain, click here.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.